Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.
Saved in:
| Title: | Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women. |
|---|---|
| Authors: | Connors KP; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA., Housman ST, Pope JS, Russomanno J, Salerno E, Shore E, Redican S, Nicolau DP |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014; Vol. 58 (4), pp. 2113-8. Date of Electronic Publication: 2014 Jan 27. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
